Synthesis, analgesic and anti-inflammatory activities evaluation of some bi-, tri- and tetracyclic condensed pyrimidines

被引:60
作者
Amin, Kamilia M. [1 ]
Hanna, Mona M. [1 ]
Abo-Youssef, Hanan E. [1 ]
George, Riham F. [1 ]
机构
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11562, Egypt
关键词
Condensed pyrimidines; Pyrrolo[1,2-c]pyrimidines; Tricyclic pyrimidines; Tetracyclic pyrimidines; Anti-inflammatory and analgesic; GASTROINTESTINAL TOXICITY; KINASE INHIBITORS; DRUGS; DERIVATIVES; ANALOGS; CYCLOOXYGENASE-2; ANTITUMOR; DESIGN; MOUSE; ACID;
D O I
10.1016/j.ejmech.2009.06.028
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Novel series of bicyclic pyrrolo[1,2-cipyrimidines 3a-g, 5, 6a, b, and 7a, b, tricyclic pyrimido[5,4-elpyrrolo[1,2-c]pyrimidines 8a-c, 9a-g, 13a-c, 17,18a, b, 19, 20a,b and 21 and tetracyclic condensed pyrimidines 14, 22 and 23 were synthesized through different chemical reactions. Structures of all synthesized pyrimidine derivatives were supported by spectral and elemental analyses. Analgesic activity evaluation was carried out using acetic acid-induced writhing assay, and all compounds exerted comparable activity to indomethacin. The anti-inflammatory activity evaluation was performed using carrageenan-induced paw edema in rats, the potency of the bicyclic derivatives 3a-f and 7b revealed comparable activity to indomethacin without gastric ulceration. The tricyclic derivatives 13a and 20a exerted good activity, however, they induced gastric ulcers while 13b and 13c showed moderate activity without ulceration. In case of tetracyclic derivatives, compound 14 exhibited the highest potency and safety profile. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:4572 / 4584
页数:13
相关论文
共 50 条
[1]
Design, synthesis and molecular modeling study of acylated 1,2,4-triazole-3-acetates with potential anti-inflammatory activity [J].
Abdel-Megeed, Ashraf M. ;
Abdel-Rahman, Hamdy A. ;
Alkaramany, Gamal-Eldien S. ;
El-Gendy, Mahmoud A. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (01) :117-123
[2]
GASTROINTESTINAL DAMAGE ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
ALLISON, MC ;
HOWATSON, AG ;
TORRANCE, CJ ;
LEE, FD ;
RUSSELL, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (11) :749-754
[3]
SIR92 - a program for automatic solution of crystal structures by direct methods [J].
ALTOMARE, A ;
CASCARANO, G ;
GIACOVAZZO, G ;
GUAGLIARDI, A ;
BURLA, MC ;
POLIDORI, G ;
CAMALLI, M .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1994, 27 :435-435
[4]
Andrus PK, 1997, J NEUROSCI RES, V47, P650, DOI 10.1002/(SICI)1097-4547(19970315)47:6<650::AID-JNR11>3.0.CO
[5]
2-Z
[6]
Basarab G., 2007, [No title captured], Patent No. [WO2007071965, 2007071965, WO 2007071965]
[7]
Black J.G., 2005, MICROBIOLOGY PRINCIP, P446
[8]
Adenosine kinase inhibitors.: 6.: Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides and related compounds [J].
Bookser, BC ;
Ugarkar, BG ;
Matelich, MC ;
Lemus, RH ;
Allan, M ;
Tsuchiya, M ;
Nakane, M ;
Nagahisa, A ;
Wiesner, JB ;
Erion, MD .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7808-7820
[9]
Breault G.A., 2000, PCT Int. Appl, Patent No. [WO2000012485, 2000012485]
[10]
SYNTHESIS OF NOVEL 2,4-DIAMINOPYRROLO[2,3-D]PYRIMIDINES WITH ANTIOXIDANT, NEUROPROTECTIVE, AND ANTIASTHMA ACTIVITY [J].
BUNDY, GL ;
AYER, DE ;
BANITT, LS ;
BELONGA, KL ;
MIZSAK, SA ;
PALMER, JR ;
TUSTIN, JM ;
CHIN, JE ;
HALL, ED ;
LINSEMAN, KL ;
RICHARDS, IM ;
SCHERCH, HM ;
SUN, FF ;
YONKERS, PA ;
LARSON, PG ;
LIN, JM ;
PADBURY, GE ;
AARON, CS ;
MAYO, JK .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (21) :4161-4163